The baseline characteristics of the study population are summarized in Table 1. The mean age was 46.8 ± 15.4 years and 42.1% participants were men. The mean value for SWLS was 23.1 ± 5.4, for EQ-VAS was 77.9 ± 14.5, and for BDI was 6.7 ± 6.6. The mean BMI was 24.6 ± 3.1, 51.9% of population were of normal weight and 48.1% were overweight. The characteristics of participants according sex are presented in Table 1. There was no statistically significant difference between the genders in relation to the SWLS value (p = 0.06), while a statistically significantly higher value of EQ-VAS was found in the group of men and the BDI in the group of women, p < 0.001 and p < 0.001, respectively. Height, weight and waist circumference were significantly higher in men group than in women. There was no statistically significant difference between genders regarding the hips and thighs circumferences. Regression analysis was next used to evaluate the relationship among anthropometric variables or body composition analysis and well-being scales. The analysis was performed in gender disaggregated populations. The most significant variables are presented in Figs. 1, 2 and 3.
Table 1
Characteristics of the non-obese general population
Variable
|
Total
population
n = 726
|
Women
n = 420
|
Men
n = 306
|
P-values*
|
Age, years
|
46.76 ± 15.36
|
47.48 ± 15.29
|
45.78 ± 15.43
|
0.11
|
SWLS
|
23.09 ± 5.43
|
22.79 ± 5.57
|
23.49 ± 5.22
|
0.06
|
EQ-VAS
|
77.95 ± 14.49
|
76.42 ± 14.83
|
80.03 ± 13.80
|
< 0.001
|
BDI
|
6.66 ± 6.55
|
7.45 ± 6.69
|
5.58 ± 6.21
|
< 0.001
|
BPs, mmHg
|
121.56 ± 16.62
|
116.22 ± 15.78
|
128.91 ± 14.86
|
< 0.001
|
BPd, mmHg
|
80.22 ± 9.42
|
78.59 ± 8.90
|
82.46 ± 9.90
|
< 0.001
|
HR, bpm
|
72.08 ± 10.60
|
72.75 ± 10.49
|
71.15 ± 10.70
|
0.14
|
Anthropometric measurements and body composition analysis
|
Height, cm
|
170.23 ± 9.56
|
164.48 ± 6.36
|
178.12 ± 7.33
|
< 0.001
|
Weight, kg
|
71.64 ± 12.69
|
64.65 ± 8.74
|
81.23 ± 10.88
|
< 0.001
|
Waist, cm
|
81.97 ± 10.63
|
76.64 ± 8.38
|
89.32 ± 8.89
|
< 0.001
|
Hip, cm
|
95.99 ± 7.11
|
95.83 ± 7.63
|
96.20 ± 6.32
|
0.47
|
Thigh, cm
|
56.40 ± 4.79
|
56.19 ± 4.92
|
56.69 ± 4.59
|
0.11
|
BMI, kg/m2
|
24.62 ± 3.11
|
23.93 ± 3.18
|
25.56 ± 2.76
|
< 0.001
|
BMI < 25 kg/m2
|
377 (51.92)
|
260 (62)
|
117 (38)
|
< 0.001
|
BMI 25-29.99 kg/m2
|
349 (48.07)
|
160 (38)
|
189 (62)
|
< 0.001
|
WHR
|
0.85 ± 0.09
|
0.80 ± 0.07
|
0.93 ± 0.07
|
< 0.001
|
WHR, ≥ 0.85 women, ≥ 0.9 men
|
299 (41.18)
|
94 (22)
|
205 (67)
|
< 0.001
|
Lean Mass Index, (kg/m2)
|
16.10 ± 2.02
|
14.80 ± 1.25
|
17.86 ± 1.45
|
< 0.001
|
Fat Mass Index, (kg/m2)
|
7.77 ± 2.37
|
8.40 ± 2.34
|
6.91 ± 2.13
|
< 0.001
|
Android fat mass, kg
|
1.91 ± 0.88
|
1.72 ± 0.75
|
2.17 ± 0.97
|
< 0.001
|
Gynoid fat mass, kg
|
3.60 ± 1.05
|
3.98 ± 0.98
|
3.08 ± 0.91
|
< 0.001
|
Gynoid lean mass, kg
|
7.0 ± 1.51
|
5.96 ± 0.69
|
8.43 ± 1.11
|
< 0.001
|
Legs fat mass, kg
|
6.89 ± 2.18
|
7.85 ± 2.00
|
5.60 ± 1.67
|
< 0.001
|
Legs lean mass, kg
|
16.16 ± 3.66
|
13.71 ± 1.85
|
19.51 ± 2.76
|
< 0.001
|
AF/GF
|
0.54 ± 0.22
|
0.42 ± 0.15
|
0.69 ± 0.21
|
< 0.001
|
GF/TF
|
0.16 ± 0.07
|
0.16 ± 0.07
|
0.15 ± 0.08
|
< 0.001
|
AF/TF
|
0.08 ± 0.06
|
0.07 ± 0.04
|
0.10 ± 0.07
|
< 0.001
|
LF/TF
|
0.30 ± 0.14
|
0.32 ± 0.14
|
0.27 ± 0.14
|
< 0.001
|
GL/TL
|
0.15 ± 0.05
|
0.13 ± 0.03
|
0.18 ± 0.05
|
< 0.001
|
LL/TL
|
0.34 ± 0.11
|
0.29 ± 0.08
|
0.42 ± 0.11
|
< 0.001
|
History
|
History of hypertension
|
156 (21.49)
|
92 (22)
|
64 (21)
|
0.99
|
History of diabetes
|
29 (3.99)
|
20 (5)
|
9 (3)
|
0.22
|
History of atrial fibrillation
|
18 (2.48)
|
8 (2)
|
10 (3)
|
0.24
|
History of myocardial infarction
|
14 (1.93)
|
3 (1)
|
11 (4)
|
0.005
|
History of coronary heart disease;
|
15 (2.07)
|
6 (1)
|
9 (3)
|
0.155
|
History of peripheral artery disease
|
7 (0.96)
|
4 (1)
|
3 (1)
|
0.96
|
History of stroke
|
10 (1.38)
|
3 (1)
|
7 (2)
|
0.07
|
Currently smoking
|
147 (20.85)
|
66 (16)
|
81 (27)
|
< 0.001
|
History of hypertension
|
156 (21.49)
|
92 (22)
|
64 (21)
|
0.99
|
The data is shown as n (%), mean ± SD. SD: standard deviation; SWLS: Satisfaction With Life Scale; EQ-VAS: Euro Quality of Life Visual Analogue Scale; BDI: Beck Depression Inventory; BPs: systolic blood pressure, BPd: diastolic blood pressure, mmHg: millimeters of mercury; HR: heart rate; bpm: beats per minute; BMI: body mass index; kg: kilogram; m2: square meter; WHR: waist-hip ratio; AF/GF: android fat/gynoid fat; GF/TF: gynoid fat/total fat; AF/TF: android fat/total fat; LF/TF: legs fat/total fat; GL/TL: gynoid lean/total lean; LL/TL: legs lean/total lean.
*P-values for comparing men and women
|
Women population
In women population, a significant negative association between SWLS and android fat distribution parameters (WHR, circumference of waist, VMI, AF, AF/GF, AF/TF) was observed while height and gynoid lean mass (GL) were positively associated with SWLS. After adjustment for age (Model 1), only the relation between SWLS and WHR remained significant. Finally, WHR had negative effect on SWLS even after adjustment for age and comorbidities (Model 2). After adjustment for age and WHR (Model 3), GF/TF presented a negative impact on SWLS. EQ-VAS showed a significant negative association with age, weight, BMI, FMI, LMI and android fat distribution parameters (WHR, circumference of waist, VMI, AF, AF/GF, AF/TF). While height was positively associated with EQ-VAS. The negative association between EQ-VAS and BMI, FMI, abdominal fat distribution (WHR, circumference of waist, VMI, AF, AF/GF) remained significant after adjustment for age (Model 1). Finally, FMI and android fat distribution parameters (WHR, circumference of waist, VMI, AF, AF/GF) were inversely associated with even EQ-VAS after adjustment for age and history of CVD and DM (Model 2). In Model 3, FMI and android fat distribution parameters (VMI, AF) remain significantly associated after adjustment for age and WHR. With BDI scoring, positively associated were age and android fat distribution parameters (WHR, circumference of waist, VMI, AF/GF, AF/TF), while height and lean mass parameters (LL, GL, GL/TL, LL/TL) presented a significant negative association with BDI scoring. In Model 1, the positive association between BDI and WHR and inverse association with GL/TL, LL/TL remained significant. However, in Model 2 and Model 3, only GL/TL and LL/TL remained significant. The details are presented in Supplementary material (Tables S1, S3, S5 and S7).
Men population
In men population, no association was found between SWLS and investigated variables in univariate analysis. After adjustment for age (Model 1) and age with comorbidities (Model 2), only WHR was inversely associated with SWLS while after adjustment for age and WHR (Model 3), a positive association was found with a larger silhouette (BMI, FMI, AF) and thigh circumference. In contrast, with EQ-VAS, several parameters of anthropometric measurement and body composition measured by DEXA were significantly related. A negative relationship was found with android fat distribution parameters (WHR, waist, VMI, AF, AF/GF, AF/TF) while a positive relationship was found with the parameters of muscle tissue (LMI), especially of the legs (LL, GL, GL/TL, LL/TL). In Model 1, the inverse association between EQ-VAS and android fat distribution parameters (AF/TF) remained significant after adjustment for age. Also, a positive association between EQ-VAS and LMI, GL, GL/TL remained significant. Moreover, appeared GF/TF, LF/TF negatively correlated with EQ-VAS. Finally, thigh circumference, parameters of muscle mass (LMI) and leg muscle mass (GL, GL/TL) were positively associated; and leg fat (LF/TF) negatively associated with EQ-VAS even after adjustment for age and history of CVD and DM (Model 2.). In Model 3, the parameters of muscle mass (LMI), especially of the legs (LL, GL, GL/TL, LL/TL and thigh circumference) became more important. As shown in Table S2, a significant negative association between BDI value, muscle mass (AL, GL, GL/TL) and thigh circumference has been found. In Model 1, Model 2 and Model 3, thigh circumference, AL, GL, GL/TL remained inversely associated with BDI value. The details are presented in Supplementary material (Tables S4, S6 and S8).
To disentangle the independent relationships of body composition in non-obese individuals with subjective well-being from any additional confounding diseases, another sub analysis was performed (Supplementary materials). From above analyzed population, we excluded people with a history of CVD (AH, MI, CHD, PAD and stroke), AF, heart failure (HF), DM, chronic obstructive pulmonary disease (COPD), asthma, cancer, chronic kidney disease (CKD) with glomerular filtration rate (GFR) < 60ml/min, and any mental disorders. The baseline characteristics of this subpopulation are summarized in Table S9. In the univariate analysis in the group of women, very similar parameters were related to the scales, no new statistically significant parameters appeared. In Model 1, more parameters of android fat distribution associated with subjective well-being. Namely, SWLS scores were negatively associated with VTI (B -0.833, p = 0.005), AF/GF (B -9.323, p = 0.003) and AF/TF (B -25.418, p = 0.010). However, in men, the relationship between well-being and higher muscle mass was even more pronounced, there were new significant positive relationships with SWLS: the thigh circumference, the hip circumference and gynoid lean mass. After taking into account the age and gender, WHR (B -15.819; p = 0.001) remained negatively significant in relation to SWLS, with concomitant positive relation with thigh circumference (B 0.236, p = 0.009). Similarly, in the EQ-VAS analysis in men, an additional strong positive link appeared with thigh circumference in Model 1. In depression analysis in men, a stronger negative link with low muscle mass, especially the lower limbs was underlined. In conclusion, in this sub-population, comparable factors in women were associated with subjective well-being, while in men, a more positive relationship with thigh circumference was emphasized. Detailed analyses can be found in the Supplementary materials (Tables S10, S11, S12 and S13).